Meet our
biopolymers

Product Portfolio

Hyaluronic Acid (Sodium Hyaluronate)

Premium Pharma-grade Hyaluronic Acid (Sodium Hyaluronate)
Product Portfolio

Polynucleotides (PDRN - PN)

Premium Pharma-grade Polynucleotides
Product Portfolio

Sodium DNA

Cosmetic grade DNA
Innovation Portfolio

Recombinant Human Collagen III

Discover HTL Biotechnology’s new recombinant human collagen with unique properties.
Innovation Portfolio

Heparosan

Building on the success of Hyaluronic Acid, HTL Biotechnology now wishes to bring new opportunities with Heparosan.
Innovation Portfolio

Oligo HA

Ultra-low molecular weight Hyaluronan

Our latest news

  • Articles October 29, 2025

    HTL Inside Webinar: a success that boosts our visibility in Asia

    On October 28, 2025, HTL Biotechnology hosted its first-ever webinar, “Shaping the Future of Aesthetic Medicine with Premium Biopolymers,” a key initiative to strengthen our presence in Asia and promote the “Feel the Difference with HTL Inside” positioning among major players in aesthetic medicine.

  • Articles October 9, 2025

    HTL Biotechnology rallies for Pink October 2025

    This October, HTL Biotechnology turned pink to support breast cancer prevention.

  • Articles September 19, 2025

    HTL Biotechnology wins the Responsible Care 2025 Award

    HTL Biotechnology is the winner of the Responsible Care West Atlantic Trophy in the ‘Energy – Climate’ category for its project to reduce carbon emissions from distillation systems.

  • Articles September 13, 2025

    Looking Back at Our Presence at ESCRS 2025

    The European Society of Cataract and Refractive Surgeons (ESCRS) is a unique opportunity each year to connect with our clients and partners while gaining insights into the key trends shaping the future of ophthalmology.

    • Feel the difference with HTL inside

    Feel the difference with HTL inside

    We Are Worldwide

    A global company with a heart in Brittany

    HTL Biotechnology is the pioneer in the development and sustainable production of pharmaceutical grade biopolymers, used to develop life-changing treatments for millions of patients worldwide.

    Backed by 30 years of expertise, we now work with more than 100 clients in 30 countries. In total, over 500 million syringes of hyaluronic acid have been safely used since 2006.

    30 Years of expertise
    100+ clients
    30 countries of export
    500+ million syringes safely used since 2006

    A trusted partner

    As the market leader in pharmaceutical grade biopolymers for medical use, we work every day to :

    • Provide its customers with high-quality products ;
    • Ensure the health, safety and well-being of its employees ;
    • Control the environmental impact of its activities ;
    • Innovate in an ethical and responsible manner with its customers, suppliers and other partners.

    Have any
    questions ?

    Contact us